Mylab Discovery Solutions

Last updated

Mylab Discovery Solutions Pvt Ltd is an Indian biotechnology company that produces molecular ashish detection kits in the field of medical diagnostics, drug discovery, biomedical research and agricultural genomics. [1] [2] [3] It was founded in 2016 and is based in Pune. They were the first company in the country to make ID-NAT screening kits for quantitative HIV, Hepatitis B vaccine and Hepatitis C vaccines. [4] The company by choice does not have any external investor and does not avail of government subsidies. [4]

In March 2020 they developed the first made in India Covid-19 testing kit which has also been commercially approved by the Central Drugs Standard Control Organisation, Drug Controller General of India and Indian Council of Medical Research. [5] [6] [7] [8] The Mylab PathoDetect COVID-19 Qualitative PCR kit was developed in six weeks. [9] "These (HIV, HBV and HCV) are deadlier virus than corona virus and that experience helped us develop in a record time," the founder said. [4] Virologist Minal Dakhave Bhosale, who is MyLabs research and development chief, led the team. [10]

In May 2021, ICMR approved Mylabs covid home testing/self-testing kit. [11]

Related Research Articles

<span class="mw-page-title-main">State Research Center of Virology and Biotechnology VECTOR</span> Russian government public health agency

The State Research Center of Virology and Biotechnology VECTOR, also known as the Vector Institute, is a biological research center in Koltsovo, Novosibirsk Oblast, Russia. It has research facilities and capabilities for all levels of biological hazard, CDC levels 1–4. It is one of two official repositories for the now-eradicated smallpox virus, and was part of the system of laboratories known as the Biopreparat.

The pharmaceutical industry in India was valued at an estimated US$42 billion in 2021 and is estimated to reach $130 billion by 2030. India is the world's largest provider of generic medicines by volume, with a 20% share of total global pharmaceutical exports. It is also the largest vaccine supplier in the world by volume, accounting for more than 60% of all vaccines manufactured in the world. Indian pharmaceutical products are exported to various regulated markets including the US, UK, European Union and Canada.

Serum Institute of India (SII) is an Indian biotechnology and biopharmaceuticals company, based in Pune. It is the world's largest manufacturer of vaccines. It was founded by Cyrus Poonawalla in 1966 and is a part of Cyrus Poonawalla Group.

<span class="mw-page-title-main">Hepatitis A vaccine</span> Vaccine to prevent hepatitis A

Hepatitis A vaccine is a vaccine that prevents hepatitis A. It is effective in around 95% of cases and lasts for at least twenty years and possibly a person's entire life. If given, two doses are recommended beginning after the age of one. It is given by injection into a muscle. The first hepatitis A vaccine was approved in Europe in 1991, and the United States in 1995. It is on the World Health Organization's List of Essential Medicines.

The National Institute of Virology in Pune, India is an Indian virology research institute and part of the Indian Council of Medical Research (ICMR). It was previously known as 'Virus Research Centre' and was founded in collaboration with the Rockefeller Foundation. It has been designated as a WHO H5 reference laboratory for SE Asia region.

GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax’s development platform uses Modified Vaccinia Ankara (MVA) vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles (VLPs) in the person being vaccinated.

<span class="mw-page-title-main">Robert R. Redfield</span> American medical researcher and CDC director

Robert Ray Redfield Jr. is an American virologist who served as the Director of the U.S. Centers for Disease Control and Prevention and the Administrator of the Agency for Toxic Substances and Disease Registry from 2018 to 2021.

<span class="mw-page-title-main">DiaSorin</span> Italian biotechnology company

DiaSorin is an Italian multinational biotechnology company that produces and markets in vitro diagnostics reagent kits used in immunodiagnostics and molecular diagnostics and since July 2021, it is also active in the Life Science business. The group was founded in 2000 and is headquartered in Saluggia, Italy. Its production is at several plants located in Europe and the United States: Saluggia and Gerenzano (Italy), Dietzenbach (Germany), Stillwater, Minnesota (US), Dartford (UK). Following the acquisition of Luminex, the company acquired five additional production plants located in the United States and in Canada (Toronto). The company is a constituent of the FTSE MIB index.

HIV in pregnancy is the presence of an HIV/AIDS infection in a woman while she is pregnant. There is a risk of HIV transmission from mother to child in three primary situations: pregnancy, childbirth, and while breastfeeding. This topic is important because the risk of viral transmission can be significantly reduced with appropriate medical intervention, and without treatment HIV/AIDS can cause significant illness and death in both the mother and child. This is exemplified by data from The Centers for Disease Control (CDC): In the United States and Puerto Rico between the years of 2014–2017, where prenatal care is generally accessible, there were 10,257 infants in the United States and Puerto Rico who were exposed to a maternal HIV infection in utero who did not become infected and 244 exposed infants who did become infected.

<span class="mw-page-title-main">COVID-19 pandemic in India</span> Ongoing COVID-19 viral pandemic in India

The COVID-19 pandemic in India is a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. As of 27 September 2023, according to Indian government figures, India has the second-highest number of confirmed cases in the world with 44,998,162 reported cases of COVID-19 infection and the third-highest number of COVID-19 deaths at 532,030 deaths. In October 2021, the World Health Organization estimated 4.7 million excess deaths, both directly and indirectly related to COVID-19 to have taken place in India.

<span class="mw-page-title-main">COVID-19 pandemic in Pakistan</span> Ongoing COVID-19 viral pandemic in Pakistan

The COVID-19 pandemic in Pakistan was a part of the ongoing pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The virus was confirmed to have reached Pakistan on 26 February 2020, when two cases were recorded. On 18 March 2020, cases had been registered in all four provinces, the two autonomous territories, and Islamabad Capital Territory, and by 17 June, each district in Pakistan had recorded at least one confirmed case of COVID-19.

<span class="mw-page-title-main">COVID-19 pandemic in Ghana</span> Viral pandemic in Ghana

The COVID-19 pandemic in Ghana was a part of the worldwide pandemic of coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2. The first two cases in Ghana were confirmed on 12 March 2020, when two infected people came to Ghana, one from Norway and the other from Turkey.

<span class="mw-page-title-main">COVID-19 pandemic in Maharashtra</span> Ongoing COVID-19 viral pandemic in Maharashtra, India

The first case of the COVID-19 pandemic in the Indian state of Maharashtra was confirmed on 9 March 2020.

<span class="mw-page-title-main">Hanneke Schuitemaker</span> Dutch virologist and researcher (born 1964)

Hanneke Schuitemaker is a Dutch virologist, the Global Head of Viral Vaccine Discovery and Translational Medicine at Johnson & Johnson's Janssen Vaccines & Prevention, and a Professor of Virology at the Amsterdam University Medical Centers of the University of Amsterdam. She has been involved in the development of Janssen's Ebola vaccine and is involved in the development of a universal flu vaccine, HIV vaccine, RSV vaccine and COVID-19 vaccine.

<span class="mw-page-title-main">Kizzmekia Corbett</span> American immunologist

Kizzmekia "Kizzy" Shanta Corbett is an American viral immunologist. She is an Assistant Professor of Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health and the Shutzer Assistant Professor at the Harvard Radcliffe Institute since June 2021.

The first case of the COVID-19 pandemic in India was reported on 30 January 2020. Slowly, the pandemic spread to various states and union territories including the state of Uttarakhand. The first case was recorded in this region on 15 March.

<span class="mw-page-title-main">COVID-19 pandemic in Mizoram</span> Ongoing COVID-19 viral pandemic in Mizoram, India

The first case of the COVID-19 pandemic in India was reported on 30 January 2020, originating from China. Slowly, the pandemic spread to various states and union territories including the state of Mizoram. The first case was recorded in this region on 24 March 2020, and the first death was recorded on 28 October 2020.

<span class="mw-page-title-main">Chloe Orkin</span> British physician

Chloe Meave Orkin is a British physician and Professor of HIV/AIDS medicine at Queen Mary University of London. She works as a consultant at the Royal London Hospital, Barts Health NHS Trust. She is an internationally renowned expert in HIV therapeutics and led the first phase III clinical trial of injectable anti-retrovirals. She is immediate past Chair of the British HIV Association, where she championed the Undetectable=Untransmittable (U=U) campaign within the United Kingdom. She is president elect of the Medical Women's Federation. Orkin is gay and was on the Top 100 Lesbian influencer lists in both the UK and in the US in 2020. She considers herself a medical activist and much of her work focuses on inequalities in healthcare and in Medicine.

References

  1. ↑ "Mylab Discovery Solutions Private Limited". Dun & Bradstreet . Retrieved 28 March 2020.
  2. ↑ "Who We Are – Mylab Discovery Solutions – Translating Discovery to Delivery" . Retrieved 28 March 2020.
  3. ↑ "Anand Mahindra, Kiran Mazumdar-Shaw in awe of the 'woman behind India's first coronavirus testing kit'". The Economic Times. 28 March 2020. Retrieved 28 March 2020.
  4. 1 2 3 "Pune start-up makes affordable, accessible Covid-19 test kit". The Financial Express. 25 March 2020. Retrieved 28 March 2020.
  5. ↑ "Press Release – Mylab Discovery Solutions – Translating Discovery to Delivery" . Retrieved 28 March 2020.
  6. ↑ "Meet the woman behind India's first covid testing kit". The Economic Times. 28 March 2020. Retrieved 28 March 2020.
  7. ↑ Mishra, Dheeraj (27 March 2020). "First Indian Co. Greenlit For COVID-19 Kit Dispatches First Batch of Supplies". The Wire Science. Retrieved 28 March 2020.
  8. ↑ Pandey, Geeta (28 March 2020). "'I delivered test kit project, then delivered my baby'". BBC News. Retrieved 28 March 2020.
  9. ↑ "India can double coronavirus test kits to 200,000 in a week, thanks to Pune-based Mylabs". Business Insider. Retrieved 28 March 2020.
  10. ↑ Editor, S. T. P. (28 March 2020). "Coronavirus: Meet The Woman Behind India's First Testing Kit". SheThePeople TV. Retrieved 28 March 2020.{{cite web}}: |last= has generic name (help)
  11. ↑ "MyLab Says Its '2-Minute' Covid Self-Testing Kit Will Be Available in 7 Lakh Pharmacies Next Week". News18. 20 May 2021. Retrieved 20 May 2021.


IndianStub.png

This article about an organisation in India is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.